Grufity logoGrufity logo
StocksFundsScreenerSectorsWatchlists
MCK

MCK - McKesson Corp Stock Price, Fair Value and News

510.27USD+2.85 (+0.56%)Market Closed
Watchlist

Market Summary

USD510.27+2.85
Market Closed
0.56%

MCK Alerts

  • Big fall in earnings (Y/Y)

MCK Stock Price

View Fullscreen

MCK RSI Chart

MCK Valuation

Market Cap

68.8B

Price/Earnings (Trailing)

22.94

Price/Sales (Trailing)

0.23

EV/EBITDA

17.86

Price/Free Cashflow

22.02

MCK Price/Sales (Trailing)

MCK Profitability

Operating Margin

32.82%

EBT Margin

1.18%

Return on Equity

37.95%

Return on Assets

4.51%

Free Cashflow Yield

4.54%

MCK Fundamentals

MCK Revenue

Revenue (TTM)

301.5B

Rev. Growth (Yr)

14.77%

Rev. Growth (Qtr)

4.77%

MCK Earnings

Earnings (TTM)

3.0B

Earnings Growth (Yr)

-45.41%

Earnings Growth (Qtr)

-11.3%

Breaking Down MCK Revenue

Last 7 days

1.9%

Last 30 days

5.3%

Last 90 days

13.5%

Trailing 12 Months

38.9%

How does MCK drawdown profile look like?

MCK Financial Health

Current Ratio

0.92

Debt/Equity

0.71

Debt/Cashflow

0.62

MCK Investor Care

Dividend Yield

0.42%

Dividend/Share (TTM)

2.16

Buy Backs (1Y)

6.19%

Diluted EPS (TTM)

22.07

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
2023276.7B284.0B291.1B301.5B
2022264.0B268.4B272.0B273.9B
2021238.2B245.2B251.0B257.0B
2020231.1B231.0B234.2B237.6B
2019214.3B217.4B222.0B224.9B
2018208.4B209.9B210.9B213.5B
2017198.5B199.9B202.0B205.4B
2016190.9B193.1B194.3B196.5B
2015179.0B183.1B187.7B189.1B
2014137.4B148.6B159.8B172.0B
2013122.1B123.6B126.8B130.1B
2012122.7B123.5B123.0B123.3B
2011112.1B114.6B117.3B119.9B
2010108.7B109.5B109.9B109.9B
2009106.6B106.6B107.1B108.3B
2008101.7B102.9B104.2B105.4B

Tracking the Latest Insider Buys and Sells of McKesson Corp

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Feb 13, 2024
smith leann b
sold
-92,256
496
-186
evp & chief hr officer
Feb 10, 2024
smith leann b
acquired
-
-
507
evp & chief hr officer
Feb 10, 2024
smith leann b
sold (taxes)
-67,682
501
-135
evp & chief hr officer
Jan 03, 2024
tyler brian s.
acquired
1,945,900
138
14,026
chief executive officer
Jan 03, 2024
tyler brian s.
sold
-6,732,480
480
-14,026
chief executive officer
Nov 13, 2023
tyler brian s.
sold
-4,944,870
470
-10,521
chief executive officer
Nov 13, 2023
tyler brian s.
acquired
1,459,620
138
10,521
chief executive officer
Nov 07, 2023
tyler brian s.
sold
-10,963,300
457
-23,963
chief executive officer
Nov 03, 2023
smith leann b
sold
-304,432
461
-660
evp & chief hr officer
Oct 12, 2023
tyler brian s.
acquired
1,459,620
138
10,521
chief executive officer

1–10 of 50

Which funds bought or sold MCK recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Feb 21, 2024
V-Square Quantitative Management LLC
unchanged
-
13,558
223,156
0.04%
Feb 21, 2024
American Trust
reduced
-3.69
19,119
772,714
0.06%
Feb 21, 2024
Raleigh Capital Management Inc.
added
3.26
37,406
410,990
0.19%
Feb 20, 2024
Pacific Center for Financial Services
unchanged
-
9,733
160,192
0.05%
Feb 20, 2024
Sunpointe, LLC
new
-
501,152
501,152
0.64%
Feb 20, 2024
Quarry LP
added
14.29
3,959
22,223
-%
Feb 20, 2024
VOISARD ASSET MANAGEMENT GROUP, INC.
new
-
14,816
14,816
0.01%
Feb 16, 2024
Sanibel Captiva Trust Company, Inc.
new
-
16,951,100
16,951,100
0.62%
Feb 16, 2024
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
added
88.9
2,451,840
4,876,570
0.01%
Feb 16, 2024
Spouting Rock Asset Management, LLC
new
-
206,489
206,489
0.08%

1–10 of 45

Are Funds Buying or Selling MCK?

Are funds buying MCK calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own MCK
No. of Funds

Unveiling McKesson Corp's Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 13, 2024
vanguard group inc
9.13%
12,145,675
SC 13G/A
Jan 25, 2024
blackrock inc.
8.8%
11,665,986
SC 13G/A
Feb 09, 2023
vanguard group inc
9.08%
12,869,151
SC 13G/A
Feb 03, 2023
blackrock inc.
8.3%
11,784,945
SC 13G/A
Feb 10, 2022
vanguard group inc
10.15%
15,497,451
SC 13G/A
Feb 01, 2022
blackrock inc.
8.6%
13,171,252
SC 13G/A
Feb 16, 2021
capital ventures international
0.5%
865,164
SC 13G/A
Feb 10, 2021
vanguard group inc
10.12%
16,251,909
SC 13G/A
Jan 29, 2021
blackrock inc.
8.7%
13,969,975
SC 13G/A
Oct 13, 2020
vanguard group inc
10.17%
16,496,553
SC 13G/A

Recent SEC filings of McKesson Corp

View All Filings
Date Filed Form Type Document
Feb 14, 2024
4
Insider Trading
Feb 13, 2024
SC 13G/A
Major Ownership Report
Feb 13, 2024
144
Notice of Insider Sale Intent
Feb 12, 2024
4
Insider Trading
Feb 12, 2024
4
Insider Trading
Feb 12, 2024
4
Insider Trading
Feb 08, 2024
10-Q
Quarterly Report
Feb 07, 2024
8-K
Current Report
Jan 25, 2024
SC 13G/A
Major Ownership Report
Jan 12, 2024
3
Insider Trading

What is the Fair Value of MCK?

Loading...
Disclaimer: Conduct thorough research and seek guidance from a certified financial advisor prior to finalizing any investment choices.

Peers (Alternatives to McKesson Corp)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
207.1B
40.1B
0.08% 5.41%
36.19
5.16
-8.12% -17.45%
70.3B
19.5B
1.90% -2.48%
56
3.61
4.02% -22.04%
24.2B
3.8B
13.67% -2.23%
66.83
6.37
-1.48% -28.97%
21.3B
14.9B
3.05% 1.38%
8.03
1.43
2.01% 209.17%
MID-CAP
10.0B
12.7B
2.56% -12.12%
22.51
0.79
0.68% -30.25%
9.9B
2.7B
6.89% -27.73%
-15.59
3.72
-4.68% 82.43%
9.3B
3.5B
8.76% 25.90%
32.84
2.68
4.97% 18.89%
7.1B
3.9B
-8.15% -6.44%
-32.48
1.81
-2.62% 73.16%
3.5B
342.6M
-1.40% 20.18%
-287.71
10.08
42.19% 84.12%
2.6B
6.6B
-4.32% -4.67%
13.13
0.4
2.61% 0.52%
SMALL-CAP
1.0B
3.1B
8.08% -63.68%
-2.41
0.33
7.95% -543.98%
363.5M
163.3M
8.18% -20.52%
-14.79
2.23
7.14% -56.09%
238.7M
329.5M
3.17% -52.24%
-16.91
0.72
0.49% 64.22%
74.1M
50.3M
4.50% -30.54%
-4.89
1.47
3.23% 20.81%
4.5M
3.7M
-15.66% 215.09%
-0.37
1.19
5.77% 8.23%

McKesson Corp News

Latest updates
MarketWatch13 hours ago
Yahoo Finance20 Feb 202402:40 pm
Yahoo Finance04 Jan 202408:00 am

McKesson Corp Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
(In Millions)
Income Statement (Quarterly)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Revenue4.8%80,89877,21574,48368,91070,49070,15767,15466,10268,61466,57662,67459,14262,59960,80855,67958,53559,17257,61655,72852,42956,208
Gross Profit2.7%3,1523,0693,0223,0663,1743,0953,0233,3183,4283,3523,0323,2973,1513,0002,7003,3363,0332,8672,7873,2012,970
Operating Expenses18.5%2,5102,1181,9222,0861,9331,9711,9872,6853,1302,8132,4642,28710,5132,3662,0222,4672,6732,2412,1533,7702,287
  S&GA Expenses19.8%2,5062,0921,8701,9641,9031,9501,9592,5313,1052,6692,2322,2242,2912,2372,097------
EBITDA Margin-20.0%0.01*0.02*0.02*0.02*0.02*0.01*0.01*0.01*0.01*-0.02*-0.02*-0.02*-0.02*0.01*0.01*0.01*-----
Interest Expenses4.9%64.0061.0047.0079.0069.0055.0045.0043.0041.0045.0049.0052.0055.0050.00-------
Income Taxes-108.5%-18.0021394.0010632927119924023813226.00316-1,20028.0015012947.00-294136111123
Earnings Before Taxes-33.2%6129161,0919321,4481,2441,0066472774425621,029-7,3636556451,201294-970619-633650
EBT Margin-21.8%0.01*0.02*0.02*0.02*0.02*0.01*0.01*0.01*0.01*-0.02*-0.02*-0.02*-0.02*0.01*0.01*0.00*-----
Net Income-11.3%5896649587871,079926768368-7.00267486666-6,2265774441,021186-730423-796469
Net Income Margin-17.0%0.01*0.01*0.01*0.01*0.01*0.01*0.01*0.00*0.01*-0.02*-0.02*-0.02*-0.02*0.01*0.00*0.00*-----
Free Cashflow-81.6%164890-1,1303,2001,5601,021-1,0122,7521,3101,699-1,7153,2121,094919-1,1344,534-----
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Assets0.6%66,51266,09164,09662,32062,69063,08162,29563,29863,70863,60162,89465,01561,84561,55857,66661,24760,87358,99461,68059,67261,011
  Current Assets0.2%47,64047,53145,53944,29244,65746,44845,38346,23146,49845,58043,35045,38242,36842,34538,68242,22239,39037,35338,42838,46538,319
    Cash Equivalents-21.4%1,9832,5242,6364,6782,7742,9162,2333,9352,7542,1512,4236,2783,5773,0912,6134,0232,0651,3561,9472,9811,849
  Inventory0.3%22,02021,94520,51019,69120,65719,87619,50518,70219,02419,34220,01619,20019,21118,43516,60716,73417,02016,35616,60416,70916,951
  Net PPE1.4%2,2012,1712,1722,1772,1402,0712,0832,0922,0642,2222,5492,5812,5182,4712,3922,3652,4082,4932,4662,5482,503
  Goodwill0.4%9,9739,9349,9719,9479,9349,2399,3689,4519,4629,4739,5209,4939,5119,4149,4199,3609,4569,4083889,358386
  Current Liabilities1.0%51,66151,14748,42247,95748,00648,35747,20148,46647,45246,07543,83544,10341,93042,72438,60042,62440,05537,14537,95237,62637,424
  Short Term Borrowings-----617---372---152---2,109549--1,048
  Long Term Debt1.6%5,6255,5355,6114,6265,4524,8134,9765,0805,5185,9466,4246,4066,4675,8486,3956,3356,7347,3427,3827,2657,616
    LT Debt, Current--------------1,7601,0531,0521,0073023103301,120
    LT Debt, Non Current---------5,5185,946-6,406-5,8486,3956,3356,7347,3427,3827,2657,616
Shareholder's Equity-100.0%-7,8997,8247,7477,5367,6097,3507,2757,4117,3117,0571756,8476,0905,6535,3096,3856,6928,0688,2879,389
  Retained Earnings3.7%14,26813,76113,18212,29511,58210,5799,7329,0308,7348,8128,6188,2027,59513,89013,38413,02212,07511,96512,77012,40913,276
  Additional Paid-In Capital0.8%7,9627,8997,8247,7477,5367,6097,3507,2757,4117,3117,0576,9256,8476,7806,7116,6636,6146,5736,4836,4356,321
Shares Outstanding-100.0%-135136141143144144152154154156161160162162181183183188--
Minority Interest1.9%371364362367366518532480487484484196200200207217211210194193204
Float------48,200---30,400---23,900---25,000---
Cashflow (Last 12 Months)
(In Millions)
Cashflow (Quarterly)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Cashflow From Operations-73.7%254965-1,0523,3251,6681,107-9412,8871,3771,792-1,6223,3701,2131,021-1,0624,654-121-108-51.003,895-177
Cashflow From Investing-8.4%-180-166-149-244-41477.0039.00183-115-58.00-99.00-20568.00-148-130-170-124-156-129-230-168
Cashflow From Financing31.6%-622-909-843-1,190-1,425-572-1,181-1,989-438-1,743-2,151-517-775-46261.00-2,480949-331-872-2,544119
  Dividend Payments10.7%83.0075.0074.0076.0077.0068.0071.0071.0072.0065.0069.0067.0069.0066.0074.0072.0074.0073.0075.0076.0077.00
  Buy Backs3.3%8688406961381,9765241,0001,5157282801,008242231269--17.00500750701252500

MCK Income Statement

2023-12-31
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Millions, $ in Millions
3 Months Ended9 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2023
Dec. 31, 2022
Income Statement [Abstract]    
Revenues$ 80,898$ 70,490$ 232,596$ 207,801
Cost of sales(77,746)(67,316)(223,353)(198,509)
Gross profit3,1523,1749,2439,292
Selling, distribution, general, and administrative expenses(2,506)(1,903)(6,468)(5,812)
Claims and litigation charges, net0125
Restructuring, impairment, and related charges, net(4)(31)(84)(84)
Total operating expenses(2,510)(1,933)(6,550)(5,891)
Operating income6421,2412,6933,401
Other income, net3427698466
Interest expense(64)(69)(172)(169)
Income from continuing operations before income taxes6121,4482,6193,698
Income tax benefit (expense)18(329)(289)(799)
Income from continuing operations6301,1192,3302,899
Income (loss) from discontinued operations, net of tax010(3)
Net income6301,1202,3302,896
Net income attributable to noncontrolling interests(41)(41)(119)(123)
Net income attributable to McKesson Corporation$ 589$ 1,079$ 2,211$ 2,773
Diluted    
Continuing operations (in usd per share)$ 4.42$ 7.65$ 16.39$ 19.32
Discontinued operations (in usd per share)00.010(0.02)
Total (in dollars per share)4.427.6616.3919.30
Basic    
Continuing operations (in usd per share)4.457.7016.4919.48
Discontinued operations (in usd per share)00.010(0.02)
Total (in dollars per share)$ 4.45$ 7.71$ 16.49$ 19.46
Weighted-average common shares outstanding    
Diluted (in usd per share)133.3141.0134.9143.7
Basic (in shares)132.5139.9134.0142.5

MCK Balance Sheet

2023-12-31
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Millions
Dec. 31, 2023
Mar. 31, 2023
Current assets  
Cash and cash equivalents$ 1,982$ 4,678
Receivables, net23,06619,410
Inventories, net22,02019,691
Prepaid expenses and other572513
Total current assets47,64044,292
Property, plant, and equipment, net2,2012,177
Operating lease right-of-use assets1,6791,635
Goodwill9,9739,947
Intangible assets, net2,0972,277
Other non-current assets2,9221,992
Total assets66,51262,320
Current liabilities  
Drafts and accounts payable46,69942,490
Short-term borrowings2180
Current portion of long-term debt48968
Current portion of operating lease liabilities296299
Other accrued liabilities4,4004,200
Total current liabilities51,66147,957
Long-term debt5,6254,626
Long-term deferred tax liabilities9781,387
Long-term operating lease liabilities1,4211,402
Long-term litigation liabilities6,1286,625
Other non-current liabilities2,3811,813
McKesson Corporation stockholders’ deficit  
Preferred stock, $0.01 par value, 100 shares authorized, no shares issued or outstanding00
Common stock, $0.01 par value, 800 shares authorized, 278 and 277 shares issued at December 31, 2023 and March 31, 2023, respectively33
Additional paid-in capital7,9627,747
Retained earnings14,26812,295
Accumulated other comprehensive loss(812)(905)
Treasury shares, at cost, 147 and 141 shares at December 31, 2023 and March 31, 2023, respectively(23,474)(20,997)
Total McKesson Corporation stockholders’ deficit(2,053)(1,857)
Noncontrolling interests371367
Total deficit(1,682)(1,490)
Total liabilities and deficit$ 66,512$ 62,320
MCK
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners and patients to address medication challenges for patients by working across healthcare; connects patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver innovative solutions to help people get the medicine needed to live healthier lives; and provides prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The International segment offers distribution and services to wholesale, institutional, and retail customers in Europe and Canada. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
 CEO
 WEBSITEwww.mckesson.com
 EMPLOYEES45000

McKesson Corp Frequently Asked Questions


What is the ticker symbol for McKesson Corp? What does MCK stand for in stocks?

MCK is the stock ticker symbol of McKesson Corp. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of McKesson Corp (MCK)?

As of Thu Feb 22 2024, market cap of McKesson Corp is 68.78 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of MCK stock?

You can check MCK's fair value in chart for subscribers.

What is the fair value of MCK stock?

You can check MCK's fair value in chart for subscribers. The fair value of McKesson Corp is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of McKesson Corp is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for MCK so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is McKesson Corp a good stock to buy?

The fair value guage provides a quick view whether MCK is over valued or under valued. Whether McKesson Corp is cheap or expensive depends on the assumptions which impact McKesson Corp's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for MCK.

What is McKesson Corp's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Thu Feb 22 2024, MCK's PE ratio (Price to Earnings) is 22.94 and Price to Sales (PS) ratio is 0.23. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. MCK PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on McKesson Corp's stock?

In the past 10 years, McKesson Corp has provided 0.12 (multiply by 100 for percentage) rate of return.